- Home
- SW vs ILMN Comparison
SW vs ILMN Comparison
Compare SW & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SW
- ILMN
- Stock Information
- Founded
- SW 1934
- ILMN 1998
- Country
- SW Ireland
- ILMN United States
- Employees
- SW N/A
- ILMN N/A
- Industry
- SW
- ILMN Medical Specialities
- Sector
- SW
- ILMN Health Care
- Exchange
- SW Nasdaq
- ILMN Nasdaq
- Market Cap
- SW 28.4B
- ILMN 23.6B
- IPO Year
- SW N/A
- ILMN 2000
- Fundamental
- Price
- SW $53.08
- ILMN $147.24
- Analyst Decision
- SW Buy
- ILMN Buy
- Analyst Count
- SW 8
- ILMN 19
- Target Price
- SW $59.75
- ILMN $162.67
- AVG Volume (30 Days)
- SW 3.4M
- ILMN 2.1M
- Earning Date
- SW 10-30-2024
- ILMN 02-06-2025
- Dividend Yield
- SW 2.27%
- ILMN N/A
- EPS Growth
- SW N/A
- ILMN N/A
- EPS
- SW 0.68
- ILMN N/A
- Revenue
- SW $16,432,000,000.00
- ILMN $4,390,000,000.00
- Revenue This Year
- SW $147.85
- ILMN N/A
- Revenue Next Year
- SW $11.27
- ILMN $4.28
- P/E Ratio
- SW $78.67
- ILMN N/A
- Revenue Growth
- SW 27.83
- ILMN N/A
- 52 Week Low
- SW $38.55
- ILMN $97.36
- 52 Week High
- SW $56.99
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- SW N/A
- ILMN 55.71
- Support Level
- SW N/A
- ILMN $140.67
- Resistance Level
- SW N/A
- ILMN $151.75
- Average True Range (ATR)
- SW 0.00
- ILMN 4.62
- MACD
- SW 0.00
- ILMN 0.75
- Stochastic Oscillator
- SW 0.00
- ILMN 71.27
About SW Smurfit WestRock plc Ordinary Shares
Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.